Metabolic tests to determine risk for type 1 diabetes in clinical trials
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Aims: Evaluate the reproducibility and relationship of various metabolic tests conducted as part of the Diabetes Prevention Trial—type 1 diabetes. Methods: Coefficients of variation, intraclass correlation coefficients, and Pearson correlations between the same metabolic tests performed at different times as well as the different tests were determined. Results: Fasting samples on the same day had a coefficient of variation of < 10 for C‐peptide, 11 for insulin, and 2 for glucose. Testing on separate days approximately doubled the variance. Stimulated insulin values had less variance than fasting values and there was only a moderate correlation between fasting and stimulated values on each test. While highly correlated, C‐peptide values from mixed meal tolerance tests are significantly lower than that obtained during oral glucose tolerance tests (OGTTs). Neither peak nor area under the curve C‐peptide on the oral glucose tolerance test was different between those with abnormal and normal glucose tolerance. Those with abnormal as compared with normal glucose tolerance had lower 30‐min C‐peptide and a longer time to peak C‐peptide. Conclusions: A large, multi‐centre trial, with tests performed over a decade‐long period, can provide robust data. C‐peptide data from oral glucose tolerance tests and mixed meal tolerance tests differ; therefore, the same stimulation test should be used to evaluate changes in beta cell function over time. Worsening glucose tolerance is associated with lower C‐peptide at 30 min and a delay in peak secretion on the oral glucose tolerance test. This Diabetes Prevention Trial—type 1 diabetes data can be used in planning parameters for future studies, including evaluation of new algorithms to determine risk of disease. Copyright © 2011 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of insulin in relatives of patients with type 1 diabetes mellitus
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012350 · Cited by 836
Effects of Oral Insulin in Relatives of Patients With Type 1 Diabetes
The Diabetes Prevention Trial-Type 1 Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1068 · Cited by 668 · cited 4×
“As previously described [1,2], after overnight fasting, oral glucose (Sundex, Fisher) dose was consumed at 1.”
BackgroundMethodInfluential
Cited by
Insel, R. A., Dunne, J. L., Atkinson, M. A., Chiang, J. L., Dabelea, D., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Krischer, J. P., Lernmark, Å., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1419 · Cited by 1,216
Self-citationFall in C-Peptide During First 2 Years From Diagnosis
Greenbaum, C. J., Beam, C. A., Boulware, D., Gitelman, S. E., Gottlieb, P. A., Herold, K. C., Lachin, J. M., McGee, P., Palmer, J. P., Pescovitz, M. D., et al. (2012) · Diabetes · doi:10.2337/db11-1538 · Cited by 319
Self-citationBogun, M. M., Bundy, B. N., Goland, R. S., & Greenbaum, C. J. (2020) · Diabetes Care · doi:10.2337/dc19-2288 · Cited by 72
Self-citationShort, K. R., Pratt, L. V., & Teague, A. M. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/278678 · Cited by 37
“For the IVGTT, the CV for calculated SI was 20–27% for young men in one study [30], while another study reported that the CVs for insulin and C-peptide AUCs were 22% and 19%, respectively (variation for glucose AUC and calculated SI was not given) [31].”
Metadata
- Authors
- Greenbaum, C. J., Buckingham, B., Chase, H. P., Krischer, J., & for the Diabetes Prevention Trial, T. 1. D. (. S. G.
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2011-09
- Volume
- 27
- Issue
- 6
- Pages
- 584-589
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W2062975415
- Cited by
- 12
- References
- 2
- FWCI
- 0.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolic tests to determine risk for type 1 diabetes in clinical trials. https://app.cochat.ai/papers/10.1002/dmrr.1205
- The paper
- Greenbaum, C. J., Buckingham, B., Chase, H. P., Krischer, J., & for the Diabetes Prevention Trial, T. 1. D. (. S. G. (2011). Metabolic tests to determine risk for type 1 diabetes in clinical trials. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.1205
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.